Paper29285367
Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma.
Sakuma K and 7 others. Mol Clin Oncol, 2017. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma. Papers, record 29285367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29285367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Clinical study on collagen gel droplet-embedded culture drug sensitivity test for multidrug combination chemotherapy and super selective intra-arterial infusion chemoradiotherapy in oral squamous cell carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9987506 | [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer]. | Gan To Kagaku Ryoho | 1999 | https://conductscience.org/library/papers/9987506 | PubMed |
| 2 | 19211574 | Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan. | Jpn J Clin Oncol | 2009 | https://conductscience.org/library/papers/19211574 | PubMed |
| 3 | 9226312 | Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. | Int J Radiat Oncol Biol Phys | 1997 | https://conductscience.org/library/papers/9226312 | PubMed |
| 4 | 24649243 | Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer. | Mol Clin Oncol | 2013 | https://conductscience.org/library/papers/24649243 | PubMed |
| 5 | 15735120 | Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15735120 | PubMed |
| 6 | 1732427 | A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1732427 | PubMed |
| 7 | 15628760 | [In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures]. | Gan To Kagaku Ryoho | 2004 | https://conductscience.org/library/papers/15628760 | PubMed |
| 8 | 21528231 | An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. | Int J Oncol | 1997 | https://conductscience.org/library/papers/21528231 | PubMed |
| 9 | 24318670 | Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer. | Gastric Cancer | 2014 | https://conductscience.org/library/papers/24318670 | PubMed |
| 10 | 28105171 | Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil. | Oncol Lett | 2016 | https://conductscience.org/library/papers/28105171 | PubMed |
| 11 | 14735175 | Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). | Br J Cancer | 2004 | https://conductscience.org/library/papers/14735175 | PubMed |
| 12 | 4289605 | In vitro test for sensitivity of tumor to carcinostatic agents. | Gan | 1966 | https://conductscience.org/library/papers/4289605 | PubMed |
| 13 | 21547692 | Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue. | Hum Cell | 2011 | https://conductscience.org/library/papers/21547692 | PubMed |
| 14 | 17960012 | Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17960012 | PubMed |
| 15 | 17960013 | Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17960013 | PubMed |
| 16 | 10659592 | An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures. | Kurume Med J | 1999 | https://conductscience.org/library/papers/10659592 | PubMed |
| 17 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 18 | 18487915 | [Collagen gel droplet-embedded culture drug sensitivity test in human breast cancer]. | Gan To Kagaku Ryoho | 2008 | https://conductscience.org/library/papers/18487915 | PubMed |
| 19 | 19746222 | The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer. | Cancer Res Treat | 2007 | https://conductscience.org/library/papers/19746222 | PubMed |
| 20 | 3004363 | [A cooperative phase II study of cisplatin in patients with head and neck cancer]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3004363 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34646385 | Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept. | Theranostics | 2021 | https://conductscience.org/library/papers/34646385 | PubMed |
| 31832190 | Identification of the optimal cetuximab concentration that is effective against oral squamous cell carcinoma in collagen gel droplet embedded culture drug sensitivity testing. | Mol Clin Oncol | 2020 | https://conductscience.org/library/papers/31832190 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29285367
GET https://conductscience.org/api/papers/v1/29285367/references?page=2